Related Experiment Video
Updated: Jul 18, 2026

09:01
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Bone marrow cytogenetic abnormalities of aplastic anemia
Y K Keung1, M J Pettenati, J M Cruz
1Section on Hematology-Oncology, Department of Medicine, Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, USA. ykeung@wfubmc.edu
American Journal of Hematology
|April 3, 2001
Summary
Clonal cytogenetic abnormalities are rare at the initial diagnosis of severe aplastic anemia. This study found abnormalities in only 6.7% of patients, highlighting their uncommon nature.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Aplastic anemia is a rare bone marrow failure disorder.
- Cytogenetic abnormalities are infrequently reported in aplastic anemia, especially at diagnosis.
Observation:
- A retrospective study analyzed 30 severe aplastic anemia cases (1988-1998).
- Bone marrow metaphases were unobtainable in 16 cases; 11 showed normal karyotypes.
- Cytogenetic abnormalities were detected in only 3 cases (6.7%), with clonal abnormalities in 2.
Findings:
- The study identified a low incidence of clonal cytogenetic abnormalities at initial diagnosis of severe aplastic anemia.
- Literature review revealed trisomies 6 and 8, and loss of chromosome 7 as common abnormalities.
- Trisomy 6 is more frequent at diagnosis, whereas loss of chromosome 7 is more common post-therapy.
Implications:
- The findings suggest that cytogenetic analysis at diagnosis may have limited utility for identifying clonal abnormalities in most aplastic anemia patients.
- Further research is needed to understand the prognostic significance of these rare abnormalities.
- Identifying specific chromosomal changes may aid in understanding disease progression and therapeutic responses.
More Related Videos
Related Concept Videos
Karyotyping
Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
Karyotyping
Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

